How to Take a Claim Apart

Bring the exact claim. Leave with a better decision.

This is the house method, and this page is where it lives. Eight passes, run on anything that starts asking for money before it has finished answering questions: a product page, a treatment menu, a device, an ingredient, a beautifully lit promise. Every verdict, register entry and desk on this site is reasoned out of these eight. Where a shorter version of the method appears on another page, it is a summary of this one and defers to it.

This is decision literacy, not diagnosis or individualized medical advice. The point is to separate desire, evidence, burden, and uncertainty clearly enough that you know what you are actually saying yes to.

Claim — copy the wording exactly

Do not improve the sentence for the brand. Save the wording, qualifiers, percentages, timeframe, images, footnotes, and directions as they appear. “Clinically tested,” “supports collagen,” “no downtime,” “medical grade,” and “visible results” are not conclusions. They are the beginning of the file.

If you want help translating the language into a testable promise, use the Claim Decoder.

Desire / Job — name what would have to change

• Visible: pigment, texture, redness, lines, shine, coverage, volume, contour.
• Functional: hydration, wear time, barrier support, cleansing, sun protection, recovery.
• Experiential: comfort, texture, scent, ritual, convenience, confidence, pleasure.
• Medical or structural: disease treatment, tissue change, procedural outcome, individualized candidacy. These require a higher evidentiary bar and, where appropriate, qualified clinical judgment.

A claim becomes easier to judge once it stops hiding inside adjectives.

Exact Object — identify the evidence object

Ask what the support actually studies: the finished product, one ingredient, a raw material, a device category, a prescription formulation, a consumer survey, a photograph, or a mechanism. Evidence does not automatically transfer because the names sound related.

A famous ingredient can make a formula interesting. It cannot sign the formula’s affidavit.

Evidence + Fit — check the study against the decision

• Who was studied, and how many people were included?
• What was the comparator?
• How long did the study run?
• Was the outcome visible, measured, self-reported, laboratory-based, or inferred?
• Was the product used the way a normal buyer is likely to use it?
• Who funded the work, and does that change what deserves verification?

Imperfect evidence can still be useful. The job is to keep the conclusion proportional to what was actually studied.

Evidence — inspect the image separately

Before-and-after photographs can document appearance. They can also change with lighting, angle, expression, distance, lens, timing, makeup, swelling, hydration, selection, and processing. A dramatic image may be legitimate and still be a terrible substitute for typical-outcome evidence.

If the photograph is doing most of the persuasion, ask what the photograph is not telling you.

Burden — price the whole ownership model

Write down the first price, repeat purchases or sessions, supporting products, consumables, travel, recovery, time, aftercare, maintenance, and what happens if you stop. The headline price is sometimes accurate in the same way a first date is accurate: technically part of the story, nowhere near the whole arrangement.

For aesthetic treatments, use Spa Intelligence before booking.

Uncertainty — mark what is still unknown

Unknown is an acceptable answer. Product-specific evidence may be missing. Durability may not have been studied. The population may be too narrow. Long-term safety may be unresolved. Real-world adherence may be a question mark. Keep the blank visible instead of filling it with brand confidence or reflexive skepticism.

Decision + Reassessment — choose the smallest honest verdict

• Worth it for the job: the evidence, burden, cost, and expectations line up.
• Interesting with conditions: useful, but only for a narrower purpose or buyer than the marketing implies.
• Plausible, evidence still thin: the mechanism makes sense; the finished-product result has not earned certainty.
• Good product, inflated claim: the object may be worthwhile even though the marketing is doing too much.
• Not worth the ownership model: the result may be real; the cost, maintenance, recovery, or complexity is the deal-breaker.
• Professional stop: the decision now depends on diagnosis, anatomy, prescription treatment, procedural candidacy, individual risk, or another clinical factor that editorial analysis cannot settle.

Three files, already worked

Blank fields are useful. Finished files are clearer. A device claim, an injectable claim, and a serum claim, each taken through all eight passes.

Device example — microcurrent “portable facelift”

• Desire: lifted jawline without needles.
• Claim held still: “portable facelift” / toned, contoured look.
• Evidence object: temporary stimulation on a consumer device + gel—not surgical lift data.
• Burden: device + conductive gel + ~5 min × 5 days/week.
• Verdict: interesting with conditions; structural facelift language still missing receipts.

Full ruling: Microcurrent devices. Ownership: Device ownership cost.

Injectable example — neuromodulator “$14/unit”

• Desire: softer dynamic lines on a sustainable plan.
• Claim held still: per-unit price without expected units or sessions/year.
• Evidence object: prescription treatment; cost literacy is separate from candidacy.
• Burden: units × areas × sessions/year × touch-ups × access.
• Verdict: worth the vanity only when year-one range is known and chosen on purpose.

Full math: Botox annual cost. Menu literacy: Read a treatment menu.

Serum example — “clinically proven regenerative exosomes”

• Desire: regenerative repair with prestige biology language.
• Claim held still: clinically proven + regenerative + exosomes fused into one sentence.
• Evidence object: often mechanism story; finished aesthetic data thin; no FDA-approved exosome products for aesthetic use in public FDA framing.
• Burden: prestige pricing + uncertainty + quality/regulatory questions.
• Verdict: still missing receipts for most outcome claims.

Full rulings: Exosomes · Clinically proven · Growth factors / PDRN.

The question that outlives all eight passes

Would you still want this if the marketing sentence were written in plain English?

Sometimes the answer is yes, the evidence is thin, the price is silly, and you buy it anyway — knowing precisely which of those three things you are paying for. That is a decision, and it is allowed. The other version, where you find all of that out in month seven of a maintenance schedule nobody mentioned, is the one this page exists to prevent.

How We Check the Work explains the evidence boundaries behind this standard. Treatment Room handles procedure-specific literacy. Products & Devices handles the objects that arrive with chargers, replacement parts, or unusually ambitious promises.

Take the eight passes with you. They work perfectly well pointed at this site.